Central venous access Port–Related blood stream infection caused by Cyberlindnera fabianii: A case report and literature review

IF 1.5 4区 医学 Q3 INFECTIOUS DISEASES Journal of Infection and Chemotherapy Pub Date : 2025-04-01 Epub Date: 2025-03-07 DOI:10.1016/j.jiac.2025.102662
Koichi Kawasaki , Toyomitsu Sawai , Yudai Inadomi , Shun Morimitsu , Tomonari Ikeda , Sumako Yoshioka , Nobuko Matsuo , Junichi Kadota , Katsunori Yanagihara , Hiroshi Mukae
{"title":"Central venous access Port–Related blood stream infection caused by Cyberlindnera fabianii: A case report and literature review","authors":"Koichi Kawasaki ,&nbsp;Toyomitsu Sawai ,&nbsp;Yudai Inadomi ,&nbsp;Shun Morimitsu ,&nbsp;Tomonari Ikeda ,&nbsp;Sumako Yoshioka ,&nbsp;Nobuko Matsuo ,&nbsp;Junichi Kadota ,&nbsp;Katsunori Yanagihara ,&nbsp;Hiroshi Mukae","doi":"10.1016/j.jiac.2025.102662","DOIUrl":null,"url":null,"abstract":"<div><div><em>Cyberlindnera fabianii</em>, an ascomycetous yeast, is a rare human pathogen. Here, we describe the first reported case of central venous (CV) access port–related blood-stream infection caused by <em>C. fabianii</em>. An 80-year-old Asian man presented to our department with a mass in the pancreas. A diagnosis of pancreatic cancer (cT4N0M0, cStage III) was made. A catheter with CV access port was inserted, and anticancer chemotherapy and radiotherapy was initiated. One year after the first visit, he was urgently admitted to our hospital due to recurrent hematemesis. On day 37, organism cultures of the blood and catheter tip were positive for <em>Candida pelliculosa</em> by the BD PHOENIX™ 100 system. On the basis of these findings, CV port–related blood-stream infection caused by <em>C</em>. <em>pelliculosa</em> was diagnosed, and treatment with micafungin (MCFG) was initiated. On day 51, the blood culture converted to negative. On day 65, MCFG was stopped. The cultured strain was sent to reference laboratory where <em>Cyberlindnera fabianii</em> was identified by MALDI-TOF mass spectrometry and direct sequencing of the internally transcribed spacer region. The present case report describes the first known case of CV access port–related blood-stream infection caused by <em>C. fabianii</em>. MCFG was successfully used to treat the fungemia caused by <em>C. fabianii</em>. Although the incidence of uncommon yeast species causing human infections has gradually increased in recent years, conventional biochemical methods may offer limited usefulness for identifying these rare organisms. Accordingly, MALDI-TOF mass spectrometry or molecular assays may be required to identify these uncommon fungal species.</div></div>","PeriodicalId":16103,"journal":{"name":"Journal of Infection and Chemotherapy","volume":"31 4","pages":"Article 102662"},"PeriodicalIF":1.5000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Infection and Chemotherapy","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1341321X25000595","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/7 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Cyberlindnera fabianii, an ascomycetous yeast, is a rare human pathogen. Here, we describe the first reported case of central venous (CV) access port–related blood-stream infection caused by C. fabianii. An 80-year-old Asian man presented to our department with a mass in the pancreas. A diagnosis of pancreatic cancer (cT4N0M0, cStage III) was made. A catheter with CV access port was inserted, and anticancer chemotherapy and radiotherapy was initiated. One year after the first visit, he was urgently admitted to our hospital due to recurrent hematemesis. On day 37, organism cultures of the blood and catheter tip were positive for Candida pelliculosa by the BD PHOENIX™ 100 system. On the basis of these findings, CV port–related blood-stream infection caused by C. pelliculosa was diagnosed, and treatment with micafungin (MCFG) was initiated. On day 51, the blood culture converted to negative. On day 65, MCFG was stopped. The cultured strain was sent to reference laboratory where Cyberlindnera fabianii was identified by MALDI-TOF mass spectrometry and direct sequencing of the internally transcribed spacer region. The present case report describes the first known case of CV access port–related blood-stream infection caused by C. fabianii. MCFG was successfully used to treat the fungemia caused by C. fabianii. Although the incidence of uncommon yeast species causing human infections has gradually increased in recent years, conventional biochemical methods may offer limited usefulness for identifying these rare organisms. Accordingly, MALDI-TOF mass spectrometry or molecular assays may be required to identify these uncommon fungal species.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
法氏赛博林纳虫引起中心静脉通路口相关血流感染1例并文献复习。
法氏荚膜酵母菌是一种罕见的人类病原体。在这里,我们描述了首次报道的中心静脉(CV)通道端口相关血流感染由法比亚氏梭菌引起的病例。一位80岁的亚洲男性因胰腺肿块来到我科就诊。诊断为胰腺癌(cT4N0M0, ciii期)。置有CV通道的导管,开始抗癌化疗和放疗。首次就诊一年后,因反复呕血被紧急送入我院。第37天,通过BD PHOENIX™100系统,血液和导管尖端的生物培养均为膜状假丝酵母阳性。在此基础上,诊断出由球囊c引起的CV端口相关血流感染,并开始使用micafungin (MCFG)治疗。第51天,血培养转为阴性。第65天,停止MCFG。将培养的菌株送入参比实验室,利用MALDI-TOF质谱法对fabiani Cyberlindnera进行鉴定,并对内部转录间隔区进行直接测序。本病例报告描述了第一例已知的由法比亚氏梭菌引起的CV通路口相关血流感染病例。MCFG成功地用于治疗法氏梭菌引起的真菌病。尽管近年来引起人类感染的罕见酵母菌种类的发生率逐渐增加,但传统的生化方法可能对鉴定这些罕见生物的有用性有限。因此,MALDI-TOF质谱或分子分析可能需要识别这些不常见的真菌物种。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Infection and Chemotherapy
Journal of Infection and Chemotherapy INFECTIOUS DISEASES-PHARMACOLOGY & PHARMACY
CiteScore
4.10
自引率
4.50%
发文量
303
审稿时长
47 days
期刊介绍: The Journal of Infection and Chemotherapy (JIC) — official journal of the Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases — welcomes original papers, laboratory or clinical, as well as case reports, notes, committee reports, surveillance and guidelines from all parts of the world on all aspects of chemotherapy, covering the pathogenesis, diagnosis, treatment, and control of infection, including treatment with anticancer drugs. Experimental studies on animal models and pharmacokinetics, and reports on epidemiology and clinical trials are particularly welcome.
期刊最新文献
Subcutaneous versus intramuscular adult diphtheria–tetanus–acellular pertussis (TRIBIK®) vaccination in Japanese healthcare workers: A prospective observational safety study Impact of introducing nucleic acid amplification testing for diagnosing Clostridioides difficile infection at a Japanese university hospital Differential presence of Campylobacter rectus and Veillonella spp. in pediatric appendicitis: a comparison of emergency and elective surgery cases Adherence to anti-Tuberculosis treatment during the COVID-19 pandemic: a single-centre, retrospective analysis Corrigendum to “Comparison of Clinical Characteristics of Hospitalized Pediatric Patients with Respiratory Syncytial Virus Infections before and during/after the Coronavirus Disease 2019 Pandemic in Japan -Importance of Universal Prevention using Maternal Vaccination and Nirsevimab” [J Infect Chemother 31 (2025) 102779]
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1